• About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
  • About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure

Decellularized Liver Nanofibers Enhance Liver Cell Using Non-Synthetic Polymer Blends

At a Glance

In vitro human liver models are utilized for screening pharmaceuticals and industrial chemicals, mimicking the key aspects of liver diseases for the discovery of novel molecular targets, and building tissue surrogates for implantation into patients suffering from end-stage liver failure. However, current models for growing and maintaining liver cells are not sufficient for long term usage. This work developed at Colorado State University has shown than liver cells can be cultured up to 47 days.

Background

Primary human hepatocytes (PHHs) are often used to fabricate models of liver disease given their ability to perform most liver functions such as protein synthesis, bile production, glucose and fatty acid metabolism, and the detoxification of endogenous and exogenous substances; however, PHH rapidly lose functions when cultured on their own on collagen I adsorbed onto non-physiological stiff substrates (e.g., glass and polystyrene). While the PHH phenotype can be stabilized in vitro for several weeks upon co-cultivation with certain non-parenchymal cell (NPC) types, functions still remain below those in freshly isolated PHHs typically due to the use of non-physiologic substrates. Thus, there remains a critical need to develop more physiologic substrates for PHH and PHH/NPC co-cultures alike.

Overview

This technology was developed to electrospin stable nanofibers of decellularized porcine liver ECM (PLECM) given their robust availability and the ability to support some hepatocyte functions in vitro; as control ECM, we utilized rat tail collagen-I, widely used for PHH culture due to ready availability and cost-effectiveness, and the polysaccharide, chitosan, that has been previously shown to stabilize collagen scaffolds and support some level of hepatic functions. We then cultured PHHs on their own and with different well-established NPC types, namely 3T3-J2 murine embryonic fibroblasts and primary human liver sinusoidal endothelial cells (LSECs), on the different nanofibrous scaffolds and non-fibrous control substrates; cell morphology, viability, and phenotypic functions were assessed for up to 47 days in culture.

Figure 1. SEM and confocal images of PHH/3T3-J2 co-cultures on ECM nanofibers and adsorbed ECM control. (A) SEM and (B) confocal images after 47 days of culture. For immunostaining, cultures were fixed and stained for antibodies against human albumin (hepatocyte marker, green), αSMA (fibroblast marker, pink), and DAPI (nucleus, blue). Scale bars for panel B = 100 μm.

Benefits

  • Long term use of primary liver cells to screen pharmaceutical drugs
  • Nanofiber morphology remains intact leading to suitable liver culture and phenotypic assessments
  • More in vivo like cultures

Applications

  • Screening of pharmaceutical drugs
  • No need for synthetic polymers
  • Application to human and other mammalian liver cells

Publications

Khetani, S.R., Engineering Liver Extrcellular Matrix Nanofibers to Functionally Mature iPSC-derived Liver Cells. Cytotherapy. 2025. https://doi.org/10.1016/j.jcyt.2025.04.022

Khetani, S. R., Decellularized Liver Nanofibers Enhance and Stabilize the Long-Term Functions of Primary Human Hepatocytes In Vitro. Adv. Healthcare Mater. 2023, 12, 2202302. 

Last Updated: June 2025
Opportunity

Available for Licensing
TRL: 5

IP Status

US Patent Application 18/531,019

Inventors

Matt Kipper
Liszt Coutinho Madruga
Jennifer Liu
Salman Khetani

Reference Number
2022-031
Licensing Manager

Steve Foster
Steve.Foster@colostate.edu
970-491-7100

Contact Us About this Technology
Download PDF
Download
Strata logo white
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
Serving the Colorado State University System with strategic real estate services, intellectual property protection and licensing, and financing activities.
Integrity
Reliability
Respect
Innovation
Excellence
Submit Disclosure

Newsletter Sign Up

Connect